Skip to main content

Want a detailed portfolio tracker?

Evolus (EOLS) Total Debt (2016 - 2026)

Evolus (EOLS) total debt from Dec 31, 2016 to Mar 31, 2026. The current Evolus (EOLS) total debt is $249M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Evolus (EOLS) Total Debt CAGR table

PeriodCAGR
1 Year TTM+12.25%
3 Years TTM+15.77%
5 Years TTM+5.86%
All Time TTM+19.56%

Annual Total Debt change of Evolus (EOLS)

YearTotal DebtChange
2025$249M
+9.65%
2024$227M
+8.28%
2023$210M
+31.48%
2022$159M
-9.19%
2021$176M
-37.73%
2020$282M
+75.18%
2019$161M
+84.07%
2018$87M
-61.60%
2017$228M
N/A
2016$0
N/A

Comparison Evolus (EOLS) total debt with competitors

Evolus (EOLS) total debt is $249.43M.

TickerNameTotal DebtUpside
CABRCaring Brands Inc$384473.00-99.85%
RGCRegencell Bioscience Holdings Ltd$895308.00-99.64%
APUSApimeds Pharmaceuticals US Inc$1.09M-99.56%
INMInMed Pharmaceuticals Inc$2.24M-99.10%
PRFXPRF Technologies Ltd$2.71M-98.91%
YCBDcbdMD Inc$2.97M-98.81%
IXHLIncannex Healthcare Inc$5.05M-97.98%
GELSGelteq Ltd$5.67M-97.73%
SXTCChina SXT Pharmaceuticals Inc$6.22M-97.50%
SBFMSunshine Biopharma Inc$6.41M-97.43%
CRDLCardiol Therapeutics Inc - Class A$7.22M-97.10%
CPHIChina Pharma Holdings Inc$8.12M-96.74%
SHPHShuttle Pharmaceuticals Holdings Inc$8.46M-96.61%
BGMQilian International Holding Group Ltd - Class A$8.91M-96.43%
DRRXDurect Corp$9.00M-96.39%
SNOASonoma Pharmaceuticals Inc$10.19M-95.91%
TXMDTherapeuticsMD Inc$10.61M-95.75%
TLPHTalphera Inc$11.68M-95.32%
EVOKEvoke Pharma Inc$12.29M-95.07%
BIOABioAge Labs Inc$18.53M-92.57%
BFRIBiofrontera Inc$18.72M-92.50%
AMLXAmylyx Pharmaceuticals Inc$20.44M-91.80%
RMTIRockwell Medical Inc$21.57M-91.35%
IMCCIM Cannabis Corp$28.80M-88.45%
TKNOAlpha Teknova Inc$33.73M-86.48%
SCYXScynexis Inc$36.32M-85.44%
CRONCronos Group Inc$48.30M-80.64%
CPIXCumberland Pharmaceuticals Inc$49.69M-80.08%
DERMJourney Medical Corp$60.70M-75.66%
CTORCitius Oncology Inc$65.43M-73.77%
ETONEton Pharmaceuticals Inc$67.09M-73.10%
SIGASIGA Technologies Inc$67.77M-72.83%
AYTUAytu BioPharma Inc$100.72M-59.62%
AVDLAvadel Pharmaceuticals plc$101.22M-59.42%
DCPHDeciphera Pharmaceuticals Inc$104.88M-57.95%
KMDAKamada Ltd$123.63M-50.43%
ZYBTZhengye Biotechnology Holding Ltd$129.76M-47.98%
ASRTAssertio Holdings Inc$135.67M-45.61%
ORGOOrganogenesis Holdings Inc - Class A$138.65M-44.42%
BTAIBioXcel Therapeutics Inc$139.57M-44.05%
OGIOrganiGram Holdings Inc$149.89M-39.91%
AQSTAquestive Therapeutics Inc$175.18M-29.77%
LFCRLifecore Biomedical Inc$204.72M-17.92%
ACBAurora Cannabis Inc$207.47M-16.82%
KNSAKiniksa Pharmaceuticals International plc. - Class A$219.59M-11.96%
LQDALiquidia Corp$292.95M+17.45%
INCRINC Research Holdings Inc$294.19M+17.95%
AKBAAkebia Therapeutics Inc$335.14M+34.36%
CGCCanopy Growth Corporation$348.02M+39.53%
XERSXeris Biopharma Holdings Inc$379.00M+51.95%
HROWHarrow Inc$391.19M+56.83%
DVAXDynavax Technologies Corp$412.37M+65.32%
SUPNSupernus Pharmaceuticals Inc$423.92M+69.96%
HCMHUTCHMED (China) Ltd$534.02M+114.09%
TLRYTilray Brands Inc$549.12M+120.15%
PCRXPacira BioSciences Inc$554.64M+122.36%
ESPREsperion Therapeutics Inc$770.46M+208.89%
EBSEmergent Biosolutions Inc$797.30M+219.65%
UTHRUnited Therapeutics Corp$813.10M+225.98%
ANIPANI Pharmaceuticals Inc$859.67M+244.65%
AMPHAmphastar Pharmaceuticals Inc$874.77M+250.71%
EVOEvotec SE$941.17M+277.33%
BCRXBiocryst Pharmaceuticals Inc$1.02B+308.49%
PAHCPhibro Animal Health Corp - Class A$1.08B+334.31%
LNTHLantheus Holdings Inc$1.13B+354.76%
COLLCollegium Pharmaceutical Inc$1.34B+437.04%
INDVIndivior Plc$1.34B+437.63%
NBIXNeurocrine Biosciences Inc$1.50B+500.89%
PBHPrestige Consumer Healthcare Inc$1.61B+544.19%
ALVOAlvotech$1.70B+582.95%
HIMSHims & Hers Health Inc - Class A$1.82B+630.01%
ALKSAlkermes plc$2.51B+904.91%
PRGOPerrigo Company plc$5.48B+2098.81%
ELANElanco Animal Health Inc$6.72B+2594.94%
ZTSZoetis Inc - Class A$11.92B+4679.30%
UPCUniverse Pharmaceuticals Inc$13.17B+5181.61%
HLNHaleon plc$16.12B+6361.78%
VTRSViatris Inc$22.18B+8791.03%
BHCBausch Health Companies Inc$25.58B+10155.38%
TEVATeva- Pharmaceutical Industries Ltd$31.81B+12652.68%
RDYDr. Reddy`s Laboratories Ltd$194.95B+78058.82%
TAKTakeda Pharmaceutical Company$597.16B+239309.45%